| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |